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Objectives: To determine anxiety levels of women presenting to Early Pregnancy 
Assessment Units (EPAU) with abdominal pain and/or vaginal bleeding and assess 
how these change over time and according to ultrasonographic diagnosis.   
 
Methods: We undertook a prospective cohort study in a EPAU in a large UK teaching 
hospital. Women with abdominal pain and/or vaginal bleeding in early pregnancy 
(less than 12 weeks gestation) presenting for the first time were eligible for inclusion in 
the study. State anxiety levels were assessed using the standardised short form of 
Spielberger’s state-trait anxiety inventory on three occasions (before, immediately 
after and 48-72 hours after an ultrasound scan).  Scores were correlated with 
ultrasonographic diagnosis. The diagnosis was either certain or uncertain. Certain 
diagnoses were either positive i.e. a viable intrauterine pregnancy (IUP), or negative 
i.e. a non-viable IUP or ectopic pregnancy (EP). Uncertain diagnoses included 
pregnancies of unknown location (PUL) and uncertain viability (PUV).  Statistical 
analysis involved mixed ANOVAs and the post-hoc Tukey-Kramer test. 
 
Results: 160 women were included in the study. Anxiety levels decreased over time 
for women with certain diagnoses (n=128), even when negative (n=64), and 
increased over time for women with uncertain diagnoses (n=32). Before the 
ultrasound, anxiety levels were high (21.96±1.11) and there was no significant 
difference between the five groups. Immediately after the ultrasound, anxiety levels 
were lower in the viable IUP group (n=64; 7.75±1.13) than any other group. The 
difference between the five groups was significant (p<0.005). 48-72 hours later, 
women with certain diagnoses had significantly lower anxiety levels than those with 
uncertain diagnoses (10.77±4.30 vs 22.94±1.65: p<0.005). 
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Conclusions: The experience of abdominal pain and/or vaginal bleeding in early 
pregnancy is highly anxiogenic. Following an ultrasound, the certainty of the 
diagnosis affects anxiety levels more than the positive or negative connotations 
associated with the diagnosis per se.  All healthcare providers should be aware of this 
when communicating uncertain diagnoses. 
 




Approximately one in five women experience abdominal pain and/or vaginal 
bleeding in early pregnancy.  This usually prompts referral to an Early Pregnancy 
Assessment Unit (EPAU).  Following a pelvic ultrasound, women may be given a 
certain or uncertain diagnosis.  Certain diagnoses may be positive i.e. a viable 
intrauterine pregnancy (IUP) or negative i.e. a non-viable IUP or an ectopic 
pregnancy (EP).  Uncertain diagnoses include pregnancies of unknown location (PUL) 
or uncertain viability (PUV).  PUVs are diagnosed in approximately 10% of women 
attending an EPAU and a further 8-31% of women are diagnosed with a PUL (1).  All 
women with uncertain diagnoses need to be followed up until a definitive diagnosis is 
made. Follow-up of these uncertainties utilizes limited resources and is often 
haphazard and protracted and women may deteriorate clinically during the process.   
 
Diagnostic tests, such as ultrasound, inherently harbor uncertainty. Uncertainty, 
defined as a cognitive state created when an event cannot be adequately 
structured or categorized because sufficient cues are lacking (2), occurs when the 
decision-maker is unable to assign definite values to objects and events and/or is 
unable to accurately predict outcomes (3). It is generated by events characterized 
as vague, ambiguous, unpredictable, unfamiliar, inconsistent, or lacking information 
(4).  Uncertainty in medicine can be a potent stressor (5) and has been linked to poor 
coping with health-related issues, as well as poor adaptation and recovery (4). 
 
The Transactional Model of Stress suggests that stress is the result of an interaction 
between a person and their environment.  When an individual finds the 
environmental demands taxing and/or threatening, and simultaneously feels 
insufficiently equipped to cope with them due to a lack (actual or perceived) of 
personal or environmental resources, stress is experienced.   
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Whilst there is an abundance of evidence in the literature regarding the 
psychological sequelae following miscarriage (6-11) and, to a lesser extent, EP (12), 
very little is known about how uncertain diagnoses in early pregnancy affect women.    
 
The aim of this study was to: determine anxiety levels of women presenting to EPAU 
with abdominal pain and/or vaginal bleeding and assess how these change over 




We hypothesized that the five groups (viable IUP, non-viable IUP, EP, PUL and PUV) 
would not differ significantly on trait anxiety and that levels of state anxiety would not 
differ significantly between the groups before the ultrasound procedure. Additionally 
we speculated that immediately after the ultrasound, women with a certain positive 
diagnosis/viable IUP would have the lowest levels of state anxiety compared to any 
other group and that 48-72 hours after the ultrasound, women with any certain 
diagnosis would have lower levels of state anxiety than women with any uncertain 
diagnosis.  Finally, we hypothesized that state anxiety levels would decrease over 
time for women with certain diagnoses, (especially if they were also positive), and 






All women presenting to the EPAU at the Queen’s Medical Centre, Nottingham with 
abdominal pain and/or vaginal bleeding between 1st February 2015 and 30th April 
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2015 were eligible to take part in the study.  Upon arrival to the Unit, a brief history was 
taken using a standardized clerking proforma by a nurse specialist.  A pelvic 
ultrasound scan, performed either transabdominally or transvaginally depending on 
the estimated gestational age, was then conducted by a trained ultrasonographer.  
Following the ultrasound, a diagnosis of a viable IUP, non-viable IUP, EP, PUL or PUV 
was made.  A viable IUP was confirmed by the presence of an intrauterine gestation 
sac with a fetal pole of any length with demonstrable fetal heart pulsations.  A non-
viable IUP was diagnosed when either there was an empty intrauterine gestation sac 
with mean sac diameter greater than 25mm or an intrauterine gestation sac 
containing a fetal pole with crown rump length greater than 7mm with no 
demonstrable fetal heart pulsations or, in the absence of a viable embryo, there was 
no significant growth of the gestation sac or fetal pole on two ultrasound scans 
performed more than 7 days apart.  Ultrasonographic appearances strongly 
suggestive of an EP included an empty endometrial cavity with either an 
inhomogenous adnexal mass or an empty extra-uterine sac or a yolk sac or fetal pole 
with or without cardiac activity in an extra-uterine sac.  A PUL was reported when, in 
the presence of a positive urinary pregnancy test, there was no ultrasonographic 
evidence of an intra- or extra-uterine pregnancy or retained products of conception.  
A PUV was defined as the presence of an intrauterine gestation sac of less than 
25mm mean diameter with no obvious yolk sac or fetal pole or an intrauterine 
gestation sac containing a fetal pole of less than 7mm with no obvious fetal heart 
pulsations. Following the ultrasound, women were reviewed by a nurse specialist or a 
gynaecology doctor, and, if necessary, a plan for further management made 
according to departmental protocols.   
 
Women were excluded from the study if they had attended the unit previously in the 
same pregnancy; if they were unable to comprehend the questions asked of them; if 
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they failed to answer all of the questions on all of the questionnaires: or if they were 
unable or unwilling to give written consent. 
 
Assessment of Anxiety 
 
Anxiety can be regarded either as a transitory emotional state or a relatively stable 
personality disposition or trait. Spielberger’s State-Trait Anxiety Inventory (STAI) 
provides operational measures of both state and trait anxiety.  It consists of two self-
report questionnaires, one for assessing state anxiety and the other for determining 
trait anxiety. The trait anxiety scale evaluates relatively stable aspects of ‘anxiety 
proneness’ including general states of calmness, confidence and security.  The 
questionnaire consists of 20 questions, including anxiety-present and anxiety-absent 
questions and are rated using a 4-point Likert scale. Responses assess the frequency 
of feelings ‘in general’ and include: (1) almost never (2) sometimes (3) often and (4) 
almost always.  Item scores are added.  Scoring is reversed for anxiety absent items.  
Scores range from 20 to 80 and higher scores represent greater levels of anxiety. 
 
The state-anxiety scale evaluates the current state of anxiety, asking how a 
respondent feels ‘right now’ using items that measure subjective feelings of 
apprehension, tension, nervousness, worry and activation/arousal of the autonomic 
nervous system.  Responses for the state anxiety scale assess the intensity of feelings 
‘at this moment’ and include: (1) not at all (2) somewhat (3) moderately so and (4) 
very much so.  Whilst there is a similar 20-question questionnaire to assess state 
anxiety, one of the benefits of the state anxiety scale over the trait anxiety scale is 
that it can be used to detect longitudinal change over a relatively short period of 
time.  Completing a 20-question questionnaire several times during a brief clinical 
encounter would be laborious.  Hence there also exists a standardized short-form of 
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the inventory (STAI-SSF) (13) which consists of only six questions and produces scores 
ranging from 6 to 24.    
 
Timing of Assessments 
 
Women were asked to complete the trait anxiety questionnaire and the first of three 
STAI-SSF questionnaires (State 1) upon arrival to the EPAU.  The second STAI-SSF 
questionnaire (State 2) was completed immediately after the ultrasound scan or as 
soon after as was considered practical (but always prior to leaving the unit).  At this 
point the questionnaires were returned to a member of the EPAU staff and the 
ultrasonographic diagnosis recorded.  Women were contacted by one of the 
investigators 48-72 hours (AR) later via telephone or e-mail using contact information 
provided exclusively for the purpose by the woman to complete the third and final 
STAI-SSF questionnaire (State 3).   
 
Questionnaires were confidential but not completely anonymous although identifying 
information was kept to an absolute minimum (appointment date and time) and only 
used for the purpose of relating the correct ultrasonographic diagnosis to each 




The reliability of the questionnaires was assessed using Cronbach’s α.  This is a 
measure of the internal consistency used to determine how much the items on a 
scale are measuring the same construct (14). It is commonly used when you have 
multiple Likert questions in a survey/questionnaire that form a scale or subscale, and 
you wish to determine if the scale is reliable.  It is expressed as a number between 0 
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and 1.  There are different reports about the acceptable values of α, ranging from 
0.70 to 0.95 (15-17). 
 
The Cronbach’s α and the corresponding levels of internal consistency for the trait 
anxiety questionnaire and the three state anxiety questionnaires are illustrated in 
Table 1.  In the state 1 questionnaire, questions 1 (I feel calm), 4 (I am relaxed) and 5 (I 
feel content) had zero variance and were removed from the scale resulting in an 
unacceptable level of internal consistency.  This is because α is affected by the 
length of the test and if this is too short, the value is reduced.  Additionally, α is 
grounded in the ‘tau equivalent model’, which assumes that each test item measures 
the same latent trait on the same scale.  If the number of test items is too small it will 
also violate the assumption of tau-equivalence and will underestimate reliability (18). 
 
To determine if trait anxiety levels were statistically significant different amongst the 
different groups, a one-way ANOVA was conducted.  To determine if state anxiety 
levels were statistically significantly different amongst the different groups at the three 
different time points, a mixed ANOVA was conducted.  A post-hoc Tukey-Kramer test 
was carried out for any statistically significant findings from the ANOVAs. Data are 
presented as mean ± standard deviation unless otherwise indicated. P-values of <0.05 










Between 1st February 2015 and 30th April 2015, 1553 women attended the EPAU at the 
Queen’s Medical Centre, Nottingham.  381 (24.5%) women were excluded because 
they had visited the Unit previously during the same pregnancy and a further 57 
(3.7%) were excluded because they were unable to understand the questions. Of the 
1115 women who were eligible to take part in the study: 670 (60.1%) did not return 
any completed questionnaires; 203 (18.2%) only completed the trait and state 1 
questionnaires; 82 (7.4%) only completed the trait, state 1 and state 2 questionnaires. 
One hundred and sixty women (14.3%) completed all four questionnaires and formed 
our study sample (Figure 1).   
 
Of these 160 women, 64 (40%) had a viable IUP, 48 (30%) a non-viable IUP, 16 (10%) 
an EP, 13 (8.1%) a PUL and 19 (11.9%) a PUV diagnosed following the ultrasound.  One 
hundred and twenty-eight (80%) therefore had a certain diagnosis (viable IUP, non-
viable IUP or EP) and 32 (20%) had an uncertain diagnosis (PUL or PUV).  Of those with 
a certain diagnosis, 64 (50%) women had a positive diagnosis (viable IUP) and a 
further 64 (50%) women had a negative diagnosis (non-viable IUP or EP).   
 
The relative frequencies of the different diagnoses were not significantly different 
amongst women that completed all four questionnaires (i.e. those that formed the 
final study sample) and women that only completed two (trait and state 1) or three 
(trait, state 1 and state 2) questionnaires  (Table 2).   
 
Similarly, irrespective of the diagnosis, there were no significant differences in the 
levels of trait or state anxiety amongst those that were included in the final study 
sample and those that were excluded due to failure to complete all four 
questionnaires (Table 3).   
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Anxiety levels in women attending the EPAU with abdominal pain and/or vaginal 
bleeding 
 
Trait anxiety levels amongst women presenting to the EPAU with abdominal pain 
and/or vaginal bleeding were generally fairly low (33.28±7.13).   
 
Overall, the level of state anxiety was 21.96±1.11 before the ultrasound, 15.89±6.83 
immediately after the ultrasound and 13.21±6.26 48-72 hours after the ultrasound.  
State anxiety levels were highest before the ultrasound and lowest 48-72 hours after 
the ultrasound in women with a: viable IUP; non-viable IUP; certain diagnosis; positive 
diagnosis; and negative diagnosis.  The opposite was true in women with a PUV or 
uncertain diagnosis.  In women with an EP or a PUL, anxiety levels were highest 
immediately after the ultrasound and lowest 48-72 hours after the ultrasound (Tables 
4, 5 and 6 and Figure 2).   
 
Anxiety levels according to diagnosis and timing of assessment 
 
We first examined whether there were any differences between the groups in the 
level of trait anxiety.  Trait anxiety was found to be modest across all groups and one-
way ANOVAs confirmed that there were no significant differences in trait anxiety 
levels between the groups.   
 
We then went on to assess whether there were any differences between the five 
specific diagnostic groups in the level of state anxiety prior to the ultrasound, 
immediately after the ultrasound and 48-72 hours after the ultrasound.   
 
Prior to the ultrasound, state anxiety levels were found to be high across all five 
specific diagnostic groups and mixed ANOVAs confirmed that there were no 
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significant differences in state anxiety levels between the specific diagnostic groups 
at this time (Table 4 and Figure 2).   
 
Immediately after the ultrasound, the mean level of state anxiety was 15.89±6.83 but 
levels ranged from 7.75±1.13 in women with a viable IUP/positive diagnosis to 
23.00±0.58 in women with a PUL (Table 4 and Figure 2).  Mixed ANOVAs confirmed 
that the differences in state anxiety levels between the groups at this time were 
significant.   
 
Immediately after the ultrasound, women with a viable IUP/certain diagnosis were the 
least anxious group.  Women with non-viable IUPs had significantly higher levels of 
state anxiety than women with viable IUPs [M=12.13, SE=0.197, p<0.005] and women 
with EPs had significantly higher levels of state anxiety than women with non-viable 
IUPs [M=2.62, SE=0.297, p<0.005]. There were no significant differences in state anxiety 
levels between women in the EP, PUV or PUL groups at this time (Table 4a and Figure 
2a).  There was a significant difference in state anxiety levels between women with 
certain diagnoses and women with uncertain diagnoses immediately after the 
ultrasound [F(1,158)=56.361, p<0.005, partial η2=0.263] (Table 4b and Figure 2b).  Of 
those with a certain diagnosis, women with a negative diagnosis had significantly 
higher levels of state anxiety than women with a positive diagnosis [M=12.78, 
SE=0.222, p<0.001] and women with an uncertain diagnosis had significantly higher 
levels of state anxiety than women with a negative diagnosis [M = 2.34, SE = 0.272, p < 
0.001] (Table 4c and Figure 2c). 
 
The mean level of state anxiety 48-72 hours after the ultrasound was 13.21±6.26 but 
levels ranged from 6.67±0.59 in women with a viable IUP/positive diagnosis to 
23.89±0.32 in women with a PUV (Tables 4, 5 and 6 and Figure 2).  Mixed ANOVAs 
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confirmed that the differences in state anxiety levels between the groups at this time 
were significant.   
 
There was a significant difference in state anxiety levels between women with a 
certain diagnosis and women with an uncertain diagnosis [F(1,158)=245.855, p<0.005, 
partial η2=0.609] 48-72 hours after the ultrasound (Table 4b and Figure 2b).  Of those 
with a certain diagnosis, women with a positive diagnosis had the lowest levels of 
state anxiety.  Women with a negative diagnosis had significantly higher levels of 
state anxiety than women with a positive diagnosis [M=8.20, SE=0.236, p<0.001] and 
women with an uncertain diagnosis had significantly higher levels of state anxiety 
than women with a negative diagnosis [M=8.06, SE=0.290, p<0.001] (Table 4c and 
Figure 2c).  More specifically, women with a viable IUP were the least anxious group 
48-72 hours after the ultrasound.  Women with non-viable IUPs had significantly higher 
levels of state anxiety than women with viable IUPs [M=7.47, SE=0.179, p<0.005] and 
women with EPs had significantly higher levels of state anxiety than women with non-
viable IUPs [M=2.92, SE=0.270, p<0.005].  Unlike immediately after the ultrasound, at 
this time women with PULs had significantly higher levels of state anxiety than women 
with EPs [M=4.48, SE=0.350, p<0.005] and women with PUVs had significantly higher 
levels of state anxiety than women with PULs [M=2.36, SE=0.337, p<0.005] (Table 4a 
and Figure 2a).   
 
Finally we examined how state anxiety levels altered over time depending on the 
diagnosis.  State anxiety levels were found to differ over time in women with a certain 
diagnosis [F(2,254)=350.762, p<0.0005, partial η2=0.734].  State anxiety levels 
decreased significantly after the ultrasound [M=-7.828, SE=0.593, p<0.001] and 
continued to do so over the next 48-72 hours [M=-3.367, SE=0.223, p<0.001] (Table 4b 
and Figure 2b).  In women with a positive diagnosis/viable IUP, state anxiety levels 
decreased significantly after the ultrasound [M =-14.281, SE=0.169, p<0.001] and 
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continued to do so over the next 48-72 hours [M =-1.078, SE=0.140, p<0.001] (Table 4c 
and Figure 2c).  In women with a negative diagnosis, state anxiety levels also 
decreased significantly after the ultrasound [M=-1.375, SE=0.259, p<0.001] and 
continued to decrease over the next 48-72 hours [M=-5.656, SE=0.122, p<0.001] but to 
a much lesser extent than that observed with a positive diagnosis (Table 3 and Figure 
1c).  More specifically, in women with non-viable IUPs, state anxiety levels decreased 
significantly immediately after the ultrasound [M=-2.042, SE=0.259, p<0.005] and 
continued to do so over the next 48-72 hours [M=-5.729, SE=0.132, p<0.005] whilst in 
women with EPs, the level of state anxiety increased very slightly [M=0.625, SE=0.375, 
p<0.349] immediately after the ultrasound but then decreased significantly [M=-5.438, 
SE=0.288, p<0.005] over the next 48-72 hours (Table 4a and Figure 2a).     
 
In women with an uncertain diagnosis, state anxiety levels were also found to differ 
over time [F(2,62)=7.267, p<0.001, partial η2=0.190] but here state anxiety levels 
increased significantly after the ultrasound [M = 0.969, SE = 0.252, p = 0.002] and then 
remained fairly constant over the next 48-72 hours [M=0.063, SE=0.317, p>0.05] (Table 
4b and Figure 2b).  More specifically, in women with PULs, the level of state anxiety 
increased very slightly [M=1.000, SE=0.376, p=0.062] immediately after the ultrasound 
but then decreased significantly [M=1.462, SE=0.462, p<0.05] over the next 48-72 hours 
to levels which were not dissimilar to those observed prior to the ultrasound [M=-0.462, 
SE=0.501, p=1.000] and in women with PUVs, state anxiety levels increased 
significantly [M=0.947, SE=0.346, p<0.05] immediately after the ultrasound and 
continued to do so over the next 48-72 hours [M=1.105, SE=0.215, p<0.005] (Table 4a 





Our results demonstrate that the propensity for anxiety, as measured by the 
Spielberger trait anxiety inventory, in women presenting to EPAU with abdominal pain 
and/or vaginal bleeding, was fairly low. Of interest however is that despite this 
general tendency towards low levels of anxiety, very high levels of state anxiety were 
reported by women in all groups prior to the ultrasound. All women scored 20 or more 
at this time indicating that the experience of abdominal pain and/or vaginal 
bleeding in early pregnancy is highly anxiogenic.  For women with certain diagnoses 
following the ultrasound, whether associated with positive or negative connotations, 
anxiety levels significantly decreased but for women with uncertain diagnoses, 
especially a PUV, anxiety levels increased.  Hence it appears to be the certainty of 
diagnosis that affects anxiety levels rather than the positive or negative connotations 
associated with it per se.   
 
Unsurprisingly, women with a viable IUP described feeling only very slightly anxious 48-
72 hours after the ultrasound. It is interesting that in the non-viable IUP group, state 
anxiety levels also decreased following the ultrasound.  However, Spielberger’s STAI 
only measures anxiety.  The high Cronbach α coefficient reflects this.   The fact that 
these women have been given a certain diagnosis, albeit a negative one, appears 
to have abated their initial anxiety, which has perhaps been replaced by other 
feelings, for example grief, sadness and depression, which are well-documented 
amongst women who have miscarried (6-11).   
 
Given the threats to health and future fertility, it is unsurprising that state anxiety levels 
in the EP group increased following the ultrasound.  What is surprising is that this was 
not significant.  This may be because there were only sixteen women in this group 
and their anxiety levels were already high, or it may be indicative of the general 
naivety of the population towards the diagnosis, or a reflection of the 
communication skills of those imparting the diagnosis.  Most EPs are treated within 48-
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72 hours of diagnosis which explains the significant decrease in anxiety levels 
observed at this time.  Again, it is worth remembering that the STAI does not measure 
constructs such as sadness and depression. There is very little evidence regarding the 
psychological sequelae following an EP (12), which, for many women is considered in 
the same light as a miscarriage.  It is, after all, a pregnancy that will never result in a 
child. 
 
In the PUL group, state anxiety levels increased slightly initially and then decreased 
significantly over the next 48-72 hours, most likely because serial serum βhCGs were 
taken, the results of which may have provided clarification.  However, whilst anxiety 
levels have significantly decreased, they were still high. 
 
In women with a PUV, there was a significant increase in anxiety levels immediately 
after the ultrasound and again 48-72 hours after.  In the UK, PUV protocols only 
advocate a repeat ultrasound 7-10 days after the initial scan (19).  Since no other 
investigations were performed, no additional information was available to alter 
anxiety levels.  Even if further investigations are not definitive, there is evidence to 
suggest that women would benefit psychologically from tests that give them an 
indication of what a subsequent ultrasound might show (20).   
 
It is extremely important that the psychological wellbeing of women undergoing 
investigation for abdominal pain and/or vaginal bleeding in early pregnancy is not 
overlooked. Our study has demonstrated that the experience of these symptoms 
alone is highly anxiogenic and that for some women, particularly those given 
uncertain diagnoses, anxiety levels remain elevated for at least 48-72 hours.  This is 
concerning since women who feel anxious in the first trimester of pregnancy have a 
much higher risk of miscarriage than those who do not (21). 
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This is the first study to assess anxiety levels of women presenting to EPAU with 
abdominal pain and/or vaginal bleeding and to determine how this changes over 
time with different types of diagnoses. The study was prospective, included a 
considerable number of women and utilised a widely adopted, validated and 
reliable measure of anxiety.  
 
Although only 14.3% of eligible women were sampled, the proportions of the different 
diagnoses were representative of the population hence there should not be any 
sampling bias.  Additionally, due to the rarity of diagnosis, the numbers of women in 
the EP, PUL and PUV groups were small.  However, since the statistical analyses took 
this into consideration and the results were extremely significant reflected by p-values 
of <0.005, this should not affect the validity of our results or conclusions drawn. 
 
Whilst we collected very little specific demographic and clinical data, all participants 
were of reproductive age and presented with abdominal pain and/or vaginal 
bleeding in early pregnancy.  Although perhaps interesting to collect more data, our 
remit was to determine how anxious women were, not why they were this anxious.  
Furthermore, we wanted to make the questionnaires as brief as possible to 
encourage participation. 
 
A further weakness of our study is that follow-up was only for 48-72 hours.  This is 
because we wanted to focus on the impact of the diagnosis itself on anxiety levels 
and felt that with longer follow-up other factors might come into play for example, 
anxiety about further management and future reproductive performance.   
 
In conclusion, this study has proven that women who present to EPAU with abdominal 
pain and/or vaginal bleeding in early pregnancy and who are subsequently given an 
uncertain diagnosis have significantly higher levels of anxiety than their counterparts 
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who are given certain diagnoses, even if those certain diagnoses are not associated 
with an ongoing pregnancy. Healthcare providers should be aware of this when 
communicating uncertain diagnoses. Women with non-viable IUPs, and to a lesser 
extent those with EPs, have access to different support groups.  Women with 
uncertain diagnoses have no such psychological support and this must be addressed 
if we are to improve the holistic nature of care provided to women with 
complications of early pregnancy.  Further research should focus on reducing the 
number of women given uncertain diagnoses in early pregnancy and/or minimizing 
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Figure 1: A flow chart to demonstrate movement of participants through the different 
phases of the study 
 
Figure 2: State anxiety levels according to (a) specific diagnosis (b) certainty of 
diagnosis and (c) type of diagnosis and timing of assessment 
 
